Strategic Investment Advisors Eli Lilly & CO Transaction History

Strategic Investment Advisors

$909 Million
Q3 2024

A detailed history of Strategic Investment Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategic Investment Advisors holds 2,447 shares of LLY stock, worth $1.94 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

2,447

Previous 2,507 2.39%

Holding current value

$1.94 Million

Previous $2.27 Million 4.5%

% of portfolio

0.24%

Previous 0.28%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$772.14 - $960.02 $46,328 - $57,601	-60 Reduced 2.39%	2,447 $2.17 Million
Q2 2024 Jul 22, 2024	SELL	$724.87 - $909.04 $4,349 - $5,454	-6 Reduced 0.24%	2,507 $2.27 Million
Q1 2024 Apr 22, 2024	SELL	$592.2 - $792.28 $39,677 - $53,082	-67 Reduced 2.6%	2,513 $1.96 Million
Q4 2023 Jan 10, 2024	BUY	$525.19 - $619.13 $181,715 - $214,218	346 Added 15.49%	2,580 $1.5 Million
Q3 2023 Oct 24, 2023	BUY	$434.7 - $599.3 $99,546 - $137,239	229 Added 11.42%	2,234 $1.2 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $70,498 - $94,264	-201 Reduced 9.11%	2,005 $940,000
Q1 2023 Apr 27, 2023	BUY	$310.63 - $364.82 $68,959 - $80,990	222 Added 11.19%	2,206 $757,000
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $1.14 Million - $1.33 Million	-3,554 Reduced 64.17%	1,984 $0
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $154,466 - $176,030	521 Added 10.38%	5,538 $1.79 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $98,112 - $115,199	352 Added 7.55%	5,017 $1.63 Million
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $182,119 - $226,328	776 Added 19.95%	4,665 $1.34 Million
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $101,182 - $125,568	450 Added 13.09%	3,889 $1.07 Million
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $55,178 - $67,904	249 Added 7.81%	3,439 $794,000
Q2 2021 Jul 22, 2021	SELL	$180.55 - $233.54 $508,609 - $657,882	-2,817 Reduced 46.9%	3,190 $732,000
Q1 2021 Apr 14, 2021	SELL	$164.32 - $212.72 $896,529 - $1.16 Million	-5,456 Reduced 47.6%	6,007 $1.12 Million
Q4 2020 Jan 13, 2021	BUY	$130.46 - $172.63 $1.14 Million - $1.51 Million	8,766 Added 325.03%	11,463 $1.94 Million
Q3 2020 Oct 14, 2020	BUY	$146.22 - $169.13 $175,756 - $203,294	1,202 Added 80.4%	2,697 $397,000
Q2 2020 Aug 04, 2020	BUY	$136.42 - $164.18 $203,947 - $245,449	1,495 New	1,495 $245,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

News

Stay updated on Strategic Investment Advisors with notifications on news.

Account

Strategic Investment Advisors Eli Lilly & CO Transaction History